Global burden of MDR-TB and XDR-TB attributable to high fasting plasma glucose from 1990 to 2019: a retrospective analysis based on the global burden of disease study 2019
Authors:
- 17 February 2024
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 43 (4) , 747-765
Abstract
Purpose High fasting plasma glucose (HFPG) has been identified as a risk factor for drug-resistant tuberculosis incidence and mortality. However, the epidemic characteristics of HFPG-attributable multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) remain unclear. We aimed to analyze the global spatial patterns and temporal trends of HFPG-attributable MDR-TB and XDR-TB from 1990 to 2019. Methods Utilizing data from the Global Burden of Disease 2019 project, annual deaths and disability-adjusted life years (DALYs) of HFPG-attributable MDR-TB and XDR-TB were conducted from 1990 to 2019. Joinpoint regression was employed to quantify trends over time. Results From 1990 to 2019, the deaths and DALYs due to HFPG-attributable MDR-TB and XDR-TB globally showed an overall increasing trend, with a significant increase until 2003 to 2004, followed by a gradual decline or stability thereafter. The low sociodemographic index (SDI) region experienced the most significant increase over the past 30 years. Regionally, Sub-Saharan Africa, Central Asia and Oceania remained the highest burden. Furthermore, there was a sex and age disparity in the burden of HFPG-attributable MDR-TB and XDR-TB, with young males in the 25–34 age group experiencing higher mortality, DALYs burden and a faster increasing trend than females. Interestingly, an increasing trend followed by a stable or decreasing pattern was observed in the ASMR and ASDR of HFPG-attributable MDR-TB and XDR-TB with SDI increasing. Conclusion The burden of HFPG-attributable MDR-TB and XDR-TB rose worldwide from 1990 to 2019. These findings emphasize the importance of routine bi-directional screening and integrated management for drug-resistant TB and diabetes.Keywords
Funding Information
- Natural Science Foundation of Shaanxi Province (2020JO-508)
This publication has 60 references indexed in Scilit:
- The Age-Specific Quantitative Effects of Metabolic Risk Factors on Cardiovascular Diseases and Diabetes: A Pooled AnalysisPLOS ONE, 2013
- Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factorsBulletin of the World Health Organization, 2012
- Prevalence of Diabetes and Pre-Diabetes and Associated Risk Factors among Tuberculosis Patients in IndiaPLOS ONE, 2012
- The impact of diabetes on tuberculosis treatment outcomes: A systematic reviewBMC Medicine, 2011
- National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participantsThe Lancet, 2011
- Commentary: Co-occurrence of tuberculosis and diabetes: new paradigm of epidemiological transitionInternational Journal of Epidemiology, 2011
- Tuberculosis and diabetes mellitus: convergence of two epidemicsThe Lancet Infectious Diseases, 2009
- Type 2 diabetes and multidrug-resistant tuberculosisScandinavian Journal of Infectious Diseases, 2008
- Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidenceBMC Public Health, 2007
- Risk factors for multidrug resistant tuberculosis in Europe: a systematic reviewThorax, 2006